David S. Tierney - 20 May 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role: Director
Signature: /s/ David S. Tierney
Issuer symbol: CPRX
Transactions as of: 20 May 2022
Net transactions value: +$50,600
Form type: 4
Filing time: 24 May 2022, 16:30:27 UTC
Previous filing: 16 Feb 2022
Next filing: 26 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CPRX	Common stock, par value $0.001 per share	Options Exercise	$50,600	+20,000	+6.5%	$2.53	328,207	20 May 2022	Direct
transaction	CPRX	Common stock, par value $0.001 per share	Sale		-20,000	-6.1%		308,207	20 May 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CPRX	Options to purchase common stock	Options Exercise	$0	-20,000	-7.3%	$0.000000	252,333	20 May 2022	Common Stock	20,000	$2.53	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Dr. Tierney has advised the Company that the sale of shares was to pay the exercise cost of the shares and to raise funds for personal reasons and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company.
F2	12,803 shares were sold at a price of $7.03 per share, 5,626 were sold at a price of $7.04 per share, and 1,571 were sold at a price of $7.05 per share.
F3	The option was granted on December 30, 2015 and previously vested in two annual installments.